Further evidence for an immediate antidepressant action of intracerebral drug administration in a model of chronic depression

International Journal of Neuropsychopharmacology

Volumn 14, Issue 5, 2011, Pages 691-696

  Lin, Yan ^a   Suckow, Raymond F ^b   Sarfraz, Yasmeen ^a   Stone, Eric A ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antidepressant; brain; mouse; stress; therapeutic lag; uptake

Indexed keywords

DESIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; DRUG METABOLISM; DRUG UPTAKE; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN; DEPRESSION; DEPRESSIVE DISORDER; DESIPRAMINE; INJECTIONS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; SWIMMING; TIME FACTORS;

EID: 79956030619     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710001161     Document Type: Article

References (22)

1. Anisman H (2009). Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. Journal of Psychiatry and Neuroscience 34, 4-20.
2. Bauer B, Hartz AM, Pekcec A, Toellner K, et al. (2008). Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling. Molecular Pharmacology 73, 1444-1453. (Pubitemid 351574834)
3. De Klerk OL, Bosker FJ, Willemsen AT, van Waarde A, et al. (2009a). Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier: an experimental PET study in rats. Journal of Psychopharmacology 24, 1237-1242.
4. 11C]verapamil as a probe for P-glycoprotein function in the blood-brain barrier. International Journal of Neuropsychopharmacology 12, 895-904.
5. Jackson MJ, Turkington D (2005). Depression and anxiety in epilepsy. Journal of Neurology, Neurosurgery and Psychiatry 76, I45-I47. (Pubitemid 40293042)
6. Kitada Y, Miyauchi T, Satoh A, Satoh S (1981). Effects of antidepressants in the rat forced swimming test. European Journal of Pharmacology 72, 145-152. (Pubitemid 11072492)
7. Koo JW, Duman RS (2008). IL-1 beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proceedings of the National Academy of Sciences USA 105, 751-756. (Pubitemid 351171780)
8. Mancinelli A, D'Aranno V, Borsini F, Meli A (1987). Lack of relationship between effect of desipramine on forced swimming test and brain levels of desipramine or its demethylated metabolite in rats. Psychopharmacology 92, 441-443. (Pubitemid 17105239)
9. Petty F, Sacquitne JL, Sherman AD (1982). Tricyclic antidepressant drug action correlates with its tissue levels in anterior neocortex. Neuropharmacology 21, 475-477. (Pubitemid 12112507)
10. Poncelet M, Gaudel G, Danti S, Soubrie P, et al. (1986). Acute vs. repeated administration of desipramine in rats and mice: relationships between brain concentrations and reduction of immobility in the swimming test. Psychopharmacology (Berlin) 90, 139-141. (Pubitemid 16075175)
11. Porsolt RD, Anton G, Blavet N, Jalfre M (1978). Behavioral despair in rats: a new model sensitive to antidepressant treatments. European Journal of Pharmacology 47, 379-381.
12. Sherman AD, Allers GL, Petty F, Henn FA (1979). A neuropharmacologically- relevant animal model of depression. Neuropharmacology 18, 891-893. (Pubitemid 10188996)
13. Simson PG, Weiss J, Hoffman LJ, Ambrose MJ (1986). Reversal of behavioral depression by infusion of an alpha-2 adrenergic agonist into the locus coeruleus. Neuropharmacology 25, 385-389. (Pubitemid 16109574)
14. Steru L, Chermat R, Thierry B, Simon P (1985). The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85, 367-370. (Pubitemid 15123115)
15. Stone EA, Lehmann ML, Lin Y, Quartermain D (2007). Reduced evoked fos expression in activity-related brain regions in animal models of depression. Progress in Neuropsychopharmacology and Biological Psychiatry 31, 1196-1207. (Pubitemid 47081304)
16. 1- adrenoceptors by a full agonist. Brain Research 1291, 21-31.
17. Stone EA, Lin Y, Sarfraz Y, Quartermain D (2010). Antidepressant-like action of intracerebral 6-fluoronorepinephrine, a selective full alpha-adrenoceptor agonist. International Journal of Neuropsychopharmacology. Published online: 12 May 2010. doi:10.1017/S1461145710000507.
18. Stone EA, Lin Y, Quartermain D (2008). Evaluation of the repeated open-space swim model of depression in the mouse. Pharmacology Biochemistry and Behavior 91, 190-195.
19. Suckow RF, Cooper TB (1981). Simultaneous determination of imipramine, desipramine, and their 2-hydroxy metabolites in plasma by ion-pair reversed-phase high-performance liquid chromatography with amperometric detection. Journal of Pharmaceutical Sciences 70, 257-261. (Pubitemid 11116058)
20. Sun MK, Alkon DL (2003). Open space swimming test to index antidepressant activity. Journal of Neuroscience Methods 126, 35-40. (Pubitemid 36683055)
21. Sun MK, Alkon DL (2006). Differential gender-related vulnerability to depression induction and converging antidepressant responses in rats. Journal of Pharmacology and Experimental Therapeutics 316, 926-932. (Pubitemid 43136539)
22. Willner P (2005). Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90-110. (Pubitemid 41160326)